![Canopy Growth CEO on cannabis sell-off thumbnail](https://i.ytimg.com/vi/CJCaac6z3ck/hqdefault.jpg)
Canopy Growth CEO on cannabis sell-off
Bruce Linton, Canopy Growth CEO, discusses the volatile moves in cannabis stocks just a week after Canada legalized recreational marijuana use.
![Green Growth mulls takeover bid for Canadian cannabis company Aphria thumbnail](https://i.ytimg.com/vi/C1yOijRg0XA/hqdefault.jpg)
Green Growth mulls takeover bid for Canadian cannabis company Aphria
CNBC’s Aditi Roy discusses Green Growth’s takeover bid of Canadian cannabis company Aphria following the country’s legalization of marijuana this year. Subscribe to CNBC: About CNBC: From ‘Wall Street’ to…
![GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC thumbnail](https://i.ytimg.com/vi/CXCat4SCSt8/hqdefault.jpg)
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…
![How illegal dispensaries are a threat to the legal cannabis industry thumbnail](https://i.ytimg.com/vi/rJEP4AsQqBM/hqdefault.jpg)
How illegal dispensaries are a threat to the legal cannabis industry
The booming business of cannabis is what many investors are calling the new gold rush. But with those potential riches comes this reality: there’s a much bigger boom in the…
![US Officials could be ready to crack down on cannabis craze thumbnail](https://i.ytimg.com/vi/0K4oTcjJJmk/hqdefault.jpg)
US Officials could be ready to crack down on cannabis craze
Are US border officials cracking down on the cannabis industry? Pot stocks get smoked. With CNBC’s Aditi Roy and Scott Wapner, and the Fast Money traders, Pete Najarian, Tim Seymour,…
![How midterm elections could impact the cannabis business thumbnail](https://i.ytimg.com/vi/IzLW-gFVVx4/hqdefault.jpg)
How midterm elections could impact the cannabis business
Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…
![Pot legislation is more likely in 2020, 2021 than this year: Cannabis analyst thumbnail](https://i.ytimg.com/vi/Wi05WHyBuvU/hqdefault.jpg)
Pot legislation is more likely in 2020, 2021 than this year: Cannabis analyst
CNBC’s “Squawk Alley” team talks about legislation that would legalize cannabis and what that means for cannabis companies with Vivien Azer, Cowen’s senior cannabis and beverage sector analyst.
![Cannabis reclassification is 'a real milestone' for the industry," says Curaleaf's Boris Jordan thumbnail](https://i.ytimg.com/vi/YAUJsiDsLdQ/hqdefault.jpg)
Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan
Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.
![Inside one of the biggest cannabis investor conferences thumbnail](https://i.ytimg.com/vi/fR5ern-W-Z4/hqdefault.jpg)
Inside one of the biggest cannabis investor conferences
The cannabis buzz. Is regulation a catalyst for pot stocks? Is it time to buy? With FM trader Tim Seymour, CNBC’s Melissa Lee and the Fast Money traders, Dan Nathan,…
![U.S. vs. Canadian cannabis stocks: Key distinctions thumbnail](https://i.ytimg.com/vi/sj1G9ddDu_4/hqdefault.jpg)
U.S. vs. Canadian cannabis stocks: Key distinctions
Tim Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS), explains the performance discrepancy between U.S. and Canadian pot stocks around U.S. elections. For access to live and exclusive video…